Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 61Neoplasms 52Neoplasm Metastasis 48Leukemia, Myeloid, Acute 47Colorectal Neoplasms 47Breast Neoplasms 44Prostatic Neoplasms 37Multiple Myeloma 33Ovarian Neoplasms 31Recurrence 27Melanoma 26Pancreatic Neoplasms 25Lymphoma, Non-Hodgkin 25Squamous Cell Carcinoma of Head and Neck 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Myelodysplastic Syndromes 22Triple Negative Breast Neoplasms 21Endometrial Neoplasms 21Lung Neoplasms 19Carcinoma, Renal Cell 19Stomach Neoplasms 18Small Cell Lung Carcinoma 18Sarcoma 18Advanced Solid Tumors 18Brain Neoplasms 17Glioblastoma 16Carcinoma, Hepatocellular 16Esophageal Neoplasms 13Solid Tumors 12Lymphoma, B-Cell 12

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Liver Diseases × 30 days × Clear all
NCT06600321 2026-06-01

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Alnylam Pharmaceuticals

Phase 1 Recruiting
158 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡